NREFMEDIUM SIGNALFINANCIAL10-K

NREF shows expanding debt burden with meaningfully higher interest expense while operating cash generation declined and credit losses improved modestly.

The substantial increase in interest expense coupled with reduced operating cash flow suggests NREF is facing pressure from higher borrowing costs in the current rate environment. However, the company strengthened its equity position and reduced credit provisions, indicating some operational resilience despite the challenging financing conditions.

Comparing 2026-03-31 vs 2025-03-27View on EDGAR →
FINANCIAL ANALYSIS

NREF's financial profile reflects a mixed picture with interest expense rising notably to $51.6M while operating cash flow declined to $22.9M, creating potential liquidity pressure. The company did show some positive signals through reduced credit loss provisions and a solid increase in stockholders' equity to $388.0M. Overall, the results suggest NREF is managing through a higher rate environment but facing headwinds on cash generation relative to its growing financing costs.

FINANCIAL STATEMENT CHANGES
Provision for Credit Losses
P&L
-40.9%
$320K$189K

Provisions reduced 40.9% — improving credit quality or reserve release boosting reported earnings.

Interest Expense
P&L
+28.1%
$40.3M$51.6M

Interest costs rose 28.1% — monitor debt levels and coverage ratio in rising rate environment.

Operating Cash Flow
Cash Flow
-21.7%
$29.3M$22.9M

Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.

Stockholders Equity
Balance Sheet
+15.3%
$336.5M$388.0M

Equity base grew 15.3% — retained earnings accumulation or equity issuance strengthening the balance sheet.

LANGUAGE CHANGES
NEW — 2026-03-31
PRIOR — 2025-03-27
ADDED
As of March 31, 2026, the registrant had 18,686,983 shares of its common stock, par value $0.01 per share, outstanding.
Form 10-K Year Ended December 31, 2025 IN DEX Page Cautionary Statement Regarding Forward-Looking Statements iii PART I Item 1.
In particular, statements relating to our liquidity and capital resources, our performance and results of operations and management's plan to refinance the 5.75% Notes (as defined below), make partial loan pay downs, and utilize extension options contractually available under the 2026 OP Notes (as defined below) and a mortgage loan due November 6, 2026 contain forward-looking statements.
bankruptcy, including related litigation and potential conflicts of interest; and Any other risks included under the heading "Risk Factors," in this Annual Report While forward-looking statements reflect our good faith beliefs, they are not guarantees of future performance.
The Company also lends to redevelopment and development projects in special situations where there is strong sponsorship and clear and visible cost basis detachment points and exit options.
+7 more — sign up free →
REMOVED
As of March 26, 2025, the registrant had 17,643,526 shares of its common stock, par value $0.01 per share, outstanding.
Form 10-K Year Ended December 31, 2024 INDEX Page Cautionary Statement Regarding Forward-Looking Statements iii PART I Item 1.
In particular, statements relating to our liquidity and capital resources, our performance and results of operations contain forward-looking statements.
In addition to OP Units, the Company holds all 2,000,000 of the issued and outstanding 8.50% Series A Cumulative Redeemable Preferred Units (liquidation preference $25.00 per unit) in our OP (the Series A Preferred Units ) and all 6,695,715 of the issued and outstanding 9.00% Series B Cumulative Redeemable Preferred Units (liquidation preference $25.00 per unit) in our OP (the Series B Preferred Units ) as of December 31, 2024.
The Company commenced operations on February 11, 2020 upon the closing of its initial public offering of shares of its common stock (the IPO ).
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →